DB008
/ DotBio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 09, 2026
PARP16 is a Druggable Regulator of Ribosome MARylation and Protein Homeostasis in Ovarian Cancer Cells.
(PubMed, J Biol Chem)
- "Finally, DB008 significantly inhibited tumor growth in OVCAR3 xenografts, with on-target engagement of PARP16 in the xenograft tumors. Collectively, these findings establish PARP16 as a druggable regulator of ribosome MARylation and protein homeostasis in ovarian cancer and provide pharmacologic proof-of-concept that disrupting ribosomal MARylation impairs tumor growth."
Journal • Oncology • Ovarian Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1